Mann Eye Institute
Houston, Texas, 76134-2099, United States
NCT Number: NCT06979557
This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
Houston, Texas, 76134-2099, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bilateral implantation with the Odyssey IOL
Time frame: 2 months posoperatively
Measured at distance (6m), intermediate at 66cm, and near visual acuity at 40cm and 33cm.
Time frame: 2 months posoperatively
Measured at distance (6m), intermediate at 66cm, and near visual acuity at 40cm and 33cm.
Time frame: 2 months posoperatively
Time frame: 2 months posoperatively
Time frame: 2 months posoperatively
The AIOLIS has 37 questions about symptoms, perceptions of general vision, and frequency of wearing glasses or contact lenses. Lower scores for the symptom questions indicate lower frequency and both of visual disturbances.
Time frame: 2 months posoperatively
Manifest refraction spherical equivalent (MRSE)
Time frame: 2 months postoperative
Time frame: 2 months postoperative
Mann Eye Institute
Other
Ambispective Analysis of Patient Reported Outcomes and Visual Acuity in Patients Undergoing a Refractive Lens Exchange With Bilateral Implantation Odyssey Intraocular Lenses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06111222
Cataract, Eye Diseases
Heidelberg, Germany
View Trial DetailsNCT03152747
Cataract, Eye Diseases
Vienna, State of Vienna, Austria
View Trial DetailsNCT05290870
Aphakia, Cataract
Spankeren, AV, Netherlands
View Trial Details